Induction of CYP2C19 and CYP3A Activity Following Repeated Administration of Efavirenz in Healthy Volunteers

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 3, 2012-03 ,pp. : 475-482

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased carrier prevalence of deficient CYP2C9, CYP2C19 and CYP2D6 alleles in depressed patients referred to a tertiary psychiatric hospital

By Ruañño Gualberto   Villagra David   Rahim Umme Salma   Windemuth Andreas   Kocherla Mohan   Bower Bruce   Szarek Bonnie L   Goethe John W  

Personalized Medicine, Vol. 5, Iss. 6, 2008-11 ,pp. : 579-587

Future Medicine

Access to resources Recommend Favorite

Interethnic and Intraethnic Variability of CYP2C8 and CYP2C9 Polymorphisms in Healthy Individuals

By García-Martín Elena  

Molecular Diagnosis & Therapy, Vol. 10, Iss. 1, 2006-01 ,pp. : 29-40

Adis International

Access to resources Recommend Favorite

CYP2C9 involvement in ACT‐453859 metabolism

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 12, 2015-12 ,pp. : 1433-1433

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preemptive Genotyping of CYP2C8 and CYP2C9 Allelic Variants Involved in NSAIDs Metabolism for Sickle Cell Disease Pain Management

By  

CLINICAL AND TRANSLATIONAL SCIENCE (ELECTRONIC), Vol. 8, Iss. 4, 2015-08 ,pp. : 272-280

John Wiley & Sons Inc

Access to resources Recommend Favorite